Seaport Therapeutics, Inc. Common Stock (SPTX) Earnings Analysis
Seaport Therapeutics, Inc. Common Stock (SPTX) next reports earnings on 2026-09-14, consensus EPS -0.71 USD. Last quarter (2026-06-08) it missed with EPS -10.34 USD vs -5.33603 USD est (-93.8%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -10.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SPTX next report earnings?
| Next earnings date | 2026-09-14 |
|---|---|
| Consensus EPS estimate | -0.71 USD |
| Revenue estimate | n/a |
SPTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-08 | -10.34 USD | -5.33603 USD | -93.8% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
SPTX valuation and analyst view
| Trailing P/E | -10.98 |
|---|---|
| Trailing EPS | -1.93759 USD |
| Price / book | -8.89 |
| Dividend yield | 0.00% |
| Market cap | 1.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Seaport Therapeutics, Inc. Common Stock (SPTX)'s next earnings date?
Seaport Therapeutics, Inc. Common Stock is next scheduled to report on 2026-09-14, with a consensus EPS estimate of -0.71 USD.
Did SPTX beat earnings last quarter?
In its 2026-06-08 report, SPTX posted EPS of -10.34 USD versus a -5.33603 USD estimate — a miss of 93.8%.
What is SPTX's earnings track record?
Over the last 1 reported quarters with consensus data, SPTX beat estimates 0 times (0%).
What is SPTX's current P/E ratio and EPS?
SPTX trades at a trailing P/E of -10.98 on trailing EPS of -1.9375901440908172 USD.
What do analysts rate SPTX?
SPTX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.